281 related articles for article (PubMed ID: 12065605)
41. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
42. Desensitization of H2-like histamine receptors stimulating cyclic AMP formation in the chick cerebral cortex.
Sedkowska P; Zawilska JB; Nowak JZ
Pol J Pharmacol; 2003; 55(2):255-9. PubMed ID: 12926556
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells.
Leurs R; Smit MJ; Menge WM; Timmerman H
Br J Pharmacol; 1994 Jul; 112(3):847-54. PubMed ID: 7921611
[TBL] [Abstract][Full Text] [Related]
44. Effects of histamine H1-, H2- and H3-receptor selective drugs on the mechanical activity of guinea-pig small and large intestine.
Leurs R; Brozius MM; Smit MJ; Bast A; Timmerman H
Br J Pharmacol; 1991 Jan; 102(1):179-85. PubMed ID: 1646056
[TBL] [Abstract][Full Text] [Related]
45. Molecular properties of central and peripheral histamine H1 and H2 receptors.
Carman-Krzan M; Lipnik-Stangelj M
Pflugers Arch; 2000; 439(3 Suppl):R131-2. PubMed ID: 10653166
[TBL] [Abstract][Full Text] [Related]
46. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.
Sharif NA; Su SX; Yanni JM
J Ocul Pharmacol; 1994; 10(4):653-64. PubMed ID: 7714409
[TBL] [Abstract][Full Text] [Related]
47. Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model.
Monczor F; Fernandez N; Legnazzi BL; Riveiro ME; Baldi A; Shayo C; Davio C
Mol Pharmacol; 2003 Aug; 64(2):512-20. PubMed ID: 12869657
[TBL] [Abstract][Full Text] [Related]
48. Characterization of histamine receptor sub-types regulating prostacyclin release from human endothelial cells.
Bull HA; Courtney PF; Rustin MH; Dowd PM
Br J Pharmacol; 1992 Oct; 107(2):276-81. PubMed ID: 1330171
[TBL] [Abstract][Full Text] [Related]
49. Role of the histamine system in nefopam-induced antinociception in mice.
Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM
Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297
[TBL] [Abstract][Full Text] [Related]
50. A study of the H2-receptor for histamine stimulating adenylate cyclase in homogenates of guinea-pig lung parenchyma.
Foreman JC; Norris DB; Rising TJ; Webber SE
Br J Pharmacol; 1986 Jan; 87(1):37-44. PubMed ID: 2869813
[TBL] [Abstract][Full Text] [Related]
51. Excitatory effects of histamine on cerebellar interpositus nuclear cells of rats through H(2) receptors in vitro.
Shen B; Li HZ; Wang JJ
Brain Res; 2002 Sep; 948(1-2):64-71. PubMed ID: 12383956
[TBL] [Abstract][Full Text] [Related]
52. Involvement of histaminergic receptor mechanisms in the stimulation of NT-3 synthesis in astrocytes.
Jurič DM; Mele T; Carman-Kržan M
Neuropharmacology; 2011 Jun; 60(7-8):1309-17. PubMed ID: 21276809
[TBL] [Abstract][Full Text] [Related]
53. Homologous down-regulation of histamine H3 receptors in rat striatal slices.
Garduño-Torres B; Arias-Montaño JA
Synapse; 2006 Aug; 60(2):165-71. PubMed ID: 16715497
[TBL] [Abstract][Full Text] [Related]
54. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
[TBL] [Abstract][Full Text] [Related]
55. Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist.
Barnes JC; Brown JD; Clarke NP; Clapham J; Evans DJ; O'Shaughnessy CT
Eur J Pharmacol; 1993 Nov; 250(1):147-52. PubMed ID: 8119312
[TBL] [Abstract][Full Text] [Related]
56. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
[TBL] [Abstract][Full Text] [Related]
57. Regulation of K+ conductance by histamine H1 and H2 receptors in neurones dissociated from rat neostriatum.
Munakata M; Akaike N
J Physiol; 1994 Oct; 480 ( Pt 2)(Pt 2):233-45. PubMed ID: 7869242
[TBL] [Abstract][Full Text] [Related]
58. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J; Sánchez JC; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[TBL] [Abstract][Full Text] [Related]
59. Structural and functional analysis of the canine histamine H2 receptor by site-directed mutagenesis: N-glycosylation is not vital for its action.
Fukushima Y; Oka Y; Saitoh T; Katagiri H; Asano T; Matsuhashi N; Takata K; van Breda E; Yazaki Y; Sugano K
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):553-8. PubMed ID: 7544576
[TBL] [Abstract][Full Text] [Related]
60. Histamine decreases myogenic tone in rat cerebral arteries by H2-receptor-mediated KV channel activation, independent of endothelium and cyclic AMP.
Jarajapu YP; Oomen C; Uteshev VV; Knot HJ
Eur J Pharmacol; 2006 Oct; 547(1-3):116-24. PubMed ID: 16920098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
